BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 8814730)

  • 1. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
    Nishimura T; Nagata S; Uehara T; Morozumi T; Ishida Y; Nakata T; Iimura O; Kurata C; Wakabayashi Y; Sugihara H; Otsuki K; Wada T; Koga Y
    Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Methyl-p-(123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy.
    Nishimura T
    Int J Card Imaging; 1999 Feb; 15(1):41-8. PubMed ID: 10453402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M; Kurihara T; Usami M; Honda M
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
    Morozumi T; Ishida Y; Hori M; Kamada T; Yamagami H; Kozuka T; Kusuoka H; Nishimura T
    Kaku Igaku; 1993 Sep; 30(9):1037-47. PubMed ID: 8230824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
    Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
    Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
    Chen SL; Uehara T; Morozumi T; Yamagami H; Kusuoka H; Nishimura T
    Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical results with beta-methyl-p-(123I)iodophenylpentadecanoic acid, single-photon emission computed tomography in cardiac disease.
    Nishimura T; Uehara T; Shimonagata T; Nagata S; Haze K
    J Nucl Cardiol; 1994; 1(2 Pt 2):S65-71. PubMed ID: 9420700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase 2 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism].
    Torizuka K; Yonekura Y; Nishimura T; Tamaki N; Uehara T
    Kaku Igaku; 1992 Mar; 29(3):305-17. PubMed ID: 1583804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
    Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
    Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Okizaki A; Yamamoto W; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.
    Yazaki Y; Isobe M; Takahashi W; Kitabayashi H; Nishiyama O; Sekiguchi M; Takemura T
    Heart; 1999 Feb; 81(2):153-9. PubMed ID: 9922350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial impairment detected by late gadolinium enhancement in hypertrophic cardiomyopathy: comparison with 99mTc-MIBI/tetrofosmin and 123I-BMIPP SPECT.
    Hashimura H; Kiso K; Yamada N; Kono A; Morita Y; Fukushima K; Higashi M; Noguchi T; Ishibashi-Ueda H; Naito H; Sugimura K
    Kobe J Med Sci; 2013 Jun; 59(3):E81-92. PubMed ID: 24045217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
    Ohtsuki K; Sugihara H; Ito K; Matsumoto K; Taniguchi Y; Terada K; Nakagawa T; Shima T; Kuribayashi T; Ochiai M
    Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy.
    Shimizu M; Yoshio H; Ino H; Taki J; Nakajima K; Bunko H; Takeda R
    Int J Cardiol; 1996 Apr; 54(1):51-9. PubMed ID: 8792185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of functional recovery and prognosis in patients with acute myocardial infarction by 123I-BMIPP and 201Tl myocardial single photon emission computed tomography: a multicenter trial.
    Nishimura T; Nishimura S; Kajiya T; Sugihara H; Kitahara K; Imai K; Muramatsu T; Takahashi N; Yoshida H; Osada T; Terada K; Ito T; Naruse H; Iwabuchi M
    Ann Nucl Med; 1998 Oct; 12(5):237-48. PubMed ID: 9839484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.